According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034.
All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...
Market Trends Shaping Executive Summary Parkinson’s Disease Treatment Market Size and Share
CAGR Value
Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period.
A complete discussion...
Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share
CAGR Value
During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine
This global RNA Therapeutics Market...
Executive Summary Nanomedicine Market Size and Share Forecast
CAGR Value
The global nanomedicine market size was valued at USD 479.30 million in 2024 and is expected to reach USD 1,247.40 million by 2032, at a CAGR of 12.70% during the forecast period
The comprehensive market information and data of the Nanomedicine report will surely grow...
According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028.
RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek